Patents by Inventor Nathan Josephsohn

Nathan Josephsohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted cyanoguanidines as oral anti-virals
    Patent number: 10112911
    Abstract: This disclosure relates to: (a) compounds and salts of formula (I), formula (II), formula (III), and formula (IV), that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: October 30, 2018
    Assignee: ABBVIE INC.
    Inventors: Artour Gomtsian, Tatyana Dekhtyar, Kristine E. Frank, Michael M. Friedman, Nathan Josephsohn, M-Akhteruzzaman Molla, Anil Vasudevan, Iok Chan Ng, Mikhail Chafeev
  • CYANOGUANIDINES AND USES THEREOF
    Publication number: 20150322045
    Abstract: This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
    Type: Application
    Filed: June 28, 2013
    Publication date: November 12, 2015
    Inventors: Artour Gomtsian, Tatyana Dekhtyar, Kristine E. Frank, Michael M. Friedman, Nathan Josephsohn, M-Akhteruzz Molla, Anil Vasudevan, Teresa Ng, Mikhail Chafeev
  • Piperazines as P2X7 antagonists
    Publication number: 20080076924
    Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, enantiomers thereof or prodrugs thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
    Type: Application
    Filed: June 29, 2007
    Publication date: March 27, 2008
    Inventors: Patrick Betschmann, William Carroll, Anna Ericsson, Shannon Fix-Stenzel, Michael Friedman, Gavin Hirst, Nathan Josephsohn, Biqin Li, Arturo Perez-Medrano, Michael Morytko, Paul Rafferty, Haipeng Chen